Cancer clinical trials in the region Bretagne

143 currently recruiting clinical trials
Region Bretagne

Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR Targeted therapy
Systemic Treatment-Naive
6 main criterias to confirm
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Locally Advanced Metastatic EGFR None Systemic Treatment-Naive
7 main criterias to confirm
Janssen
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Non-squamous NSCLC Locally Advanced EGFR None Chemotherapy Radiotherapy
8 main criterias to confirm
AstraZeneca
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized ALK None Systemic Treatment-Naive Surgery
8 main criterias to confirm
Hoffmann-La Roche
Early Access Lung cancer
NSCLC (Non-Small Cell Lung Cancer) Localized PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) None Systemic Treatment-Naive
ALK EGFR
8 main criterias to confirm
Bristol-Myers Squibb
Early Access Lung cancer
SCLC (Small Cell Lung Cancer) Localized Locally Advanced None Chemotherapy Radiotherapy Chemotherapy Radiotherapy
7 main criterias to confirm
AstraZeneca
Phase 3 Pancreas cancer
#NCT06625320
Adenocarcinoma Metastatic 1 2 3 or more
Targeted therapy Systemic Treatment-Naive Targeted therapy
8 main criterias to confirm
Centre Eugene Marquis (Rennes)
Revolution Medicines, Inc.
Phase 3 Lung cancer
#NCT06635824
NSCLC (Non-Small Cell Lung Cancer) Metastatic PDL1 Positive (1% <= X < 25%) PDL1 Positive (25% <= X < 50%) PDL1 Positive (>= 50%) 1 2 Immunotherapy Chemotherapy
ALK BRAF EGFR KRAS G12C KRAS non G12C MET RET ROS-1 Systemic Treatment-Naive Car-T
9 main criterias to confirm
CHU de Rennes - Hôpital Pontchaillou (Rennes)
Genmab
Phase 3 Kidney cancer
#NCT06364631
Clear cell carcinoma Metastatic None 0 1 or 2 Systemic Treatment-Naive
7 main criterias to confirm
Centre Eugene Marquis (Rennes)
Gustave Roussy, Campus du cancer, Grand Paris
Phase 3 Lung cancer
#NCT06312137
NSCLC (Non-Small Cell Lung Cancer) Localized Locally Advanced None Systemic Treatment-Naive Systemic Treatment-Naive
ALK
9 main criterias to confirm
Centre Hospitalier Régional Et Universitaire CHRU de Brest (Brest)
Merck Sharp & Dohme LLC